We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for Select Medical (SEM) Earnings in Q1?
Read MoreHide Full Article
Select Medical Holdings Corporation (SEM - Free Report) is slated to report first-quarter 2021 results on May 6, after the market closes.
In the fourth quarter of 2020, the company’s earnings of 57 cents per share beat the Zacks Consensus Estimate by 137.5% and also soared 84% year over year on the back of improved revenues.
Q1 Earnings & Revenue Expectations
The Zacks Consensus Estimate for earnings of 65 cents per share implies a 75.4% increase from the prior-year quarter’s reported number. Likewise, the consensus estimate for sales of $1.48 billion suggests a 4.37% rise from the year-ago quarter’s reported figure.
Factors to Note
The company’s critical illness recovery and rehabilitation hospital segments are likely to have seen top-line growth, driven by higher year-over-year occupancy rates.
Its Outpatient Rehabilitation Segment is likely to have witnessed revenue gains as the services it provided saw demand from individuals who started visiting physician offices. Also, hospitals initiated performing elective surgeries, which might have buoyed demand for the segment’s services.
The gradual subsidence of COVID-19 conditions in the United States is likely to have prompted employers and businesses to expand their workforce, thereby pushing up demand for occupational health services. Also, Concentra expanded its services to provide COVID-19 screening and testing at its centers and various onsite clinics located at employer worksites. These efforts are likely to have driven the company’s top line in the to-be-reported quarter.
Select Medical did not buy back shares in the fourth quarter of 2020 and continued absence of any share repurchase activity in the first quarter of 2021 might have further deprived its bottom line of the cushion that lower share count provides.
Earnings Surprise History
Earnings of the company beat estimates in each of the trailing four quarters, the average being 242.41%. This is shown in the chart below:
Select Medical Holdings Corporation Price and EPS Surprise
Our proven model does not predict an earnings beat for Select Medical this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of beating estimates. But this is not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: Select Medical has an Earnings ESP of 0.00%.
Zacks Rank: Select Medical currently has a Zacks Rank #3.
Stocks to Consider
Some medical stocks with the right combination of elements to come up with an earnings beat this time around are:
Kodiak Sciences Inc. (KOD - Free Report) has an Earnings ESP of +28.31% and is presently Zacks #3 Ranked.
Catalyst Biosciences, Inc. has an Earnings ESP of +13.64% and is a #3 Ranked player at present.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Image: Bigstock
What's in Store for Select Medical (SEM) Earnings in Q1?
Select Medical Holdings Corporation (SEM - Free Report) is slated to report first-quarter 2021 results on May 6, after the market closes.
In the fourth quarter of 2020, the company’s earnings of 57 cents per share beat the Zacks Consensus Estimate by 137.5% and also soared 84% year over year on the back of improved revenues.
Q1 Earnings & Revenue Expectations
The Zacks Consensus Estimate for earnings of 65 cents per share implies a 75.4% increase from the prior-year quarter’s reported number. Likewise, the consensus estimate for sales of $1.48 billion suggests a 4.37% rise from the year-ago quarter’s reported figure.
Factors to Note
The company’s critical illness recovery and rehabilitation hospital segments are likely to have seen top-line growth, driven by higher year-over-year occupancy rates.
Its Outpatient Rehabilitation Segment is likely to have witnessed revenue gains as the services it provided saw demand from individuals who started visiting physician offices. Also, hospitals initiated performing elective surgeries, which might have buoyed demand for the segment’s services.
The gradual subsidence of COVID-19 conditions in the United States is likely to have prompted employers and businesses to expand their workforce, thereby pushing up demand for occupational health services. Also, Concentra expanded its services to provide COVID-19 screening and testing at its centers and various onsite clinics located at employer worksites. These efforts are likely to have driven the company’s top line in the to-be-reported quarter.
Select Medical did not buy back shares in the fourth quarter of 2020 and continued absence of any share repurchase activity in the first quarter of 2021 might have further deprived its bottom line of the cushion that lower share count provides.
Earnings Surprise History
Earnings of the company beat estimates in each of the trailing four quarters, the average being 242.41%. This is shown in the chart below:
Select Medical Holdings Corporation Price and EPS Surprise
Select Medical Holdings Corporation price-eps-surprise | Select Medical Holdings Corporation Quote
Here is what our quantitative model predicts:
Our proven model does not predict an earnings beat for Select Medical this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of beating estimates. But this is not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: Select Medical has an Earnings ESP of 0.00%.
Zacks Rank: Select Medical currently has a Zacks Rank #3.
Stocks to Consider
Some medical stocks with the right combination of elements to come up with an earnings beat this time around are:
Adamas Pharmaceuticals, Inc. has an Earnings ESP of +1.26% and a Zacks Rank of 3, currently. You can see the complete list of today’s Zacks #1 Rank stocks here.
Kodiak Sciences Inc. (KOD - Free Report) has an Earnings ESP of +28.31% and is presently Zacks #3 Ranked.
Catalyst Biosciences, Inc. has an Earnings ESP of +13.64% and is a #3 Ranked player at present.
Infrastructure Stock Boom to Sweep America
A massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.
The only question is “Will you get into the right stocks early when their growth potential is greatest?
Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.
Download FREE: How to Profit from Trillions on Spending for Infrastructure >>